Abiopharma

🔍 Swanstrom Daniel E II (Executive)

Company: FrontView REIT, Inc. (FVR)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Acquired 850 shares of LTIP Units (Derivative)
  Date: 2026-03-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 850.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2, F3, F1

Footnotes:

• F1: Represents units of limited partnership interest designated as "LTIP Units" in FrontView Operating Partnership LP (the "Operating Partnership") granted pursuant to Issuer's 2024 Omnibus Equity and Incentive Plan and the Amended and Restated Agreement of Limited Partnership of the Operating Partnership, dated as of October 3, 2024 (the "Partnership Agreement"). LTIP Units have no expiration date.
• F2: Each LTIP Unit may be converted at the election of the Issuer or the holder, into a common unit of limited partnership interest in the Operating Partnership (an "OP Unit") only if the vesting conditions described below are met. Each OP Unit is thereafter redeemable at the election of the holder for cash equal to the then fair market value of one share of the Issuer's common stock (a "Share"), or at the Issuer's election, one Share, subject to adjustment as set forth in the Partnership Agreement.
• F3: These LTIP Units generally vest in full on the earlier of (i) the first anniversary of the date of issuance and (ii) the day before the Issuer's first annual stockholders' meeting that is held at least 50 weeks following the date of issuance, in either case, subject to continued service with the Issuer through the applicable date.